Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05587764
Other study ID # CCTCRDTTempusProRegi20211168
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date April 25, 2024
Est. completion date June 28, 2024

Study information

Verified date May 2024
Source Philips Clinical & Medical Affairs Global
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

A multicenter, prospective and retrospective, observational, post market study.


Description:

This observational study is to collect real-world data on the safety and performance of the Tempus Pro device, its accessories and the IntelliSpace Corsium telemedicine software device when used according to its intended purpose and the instructions for use, when used for patient monitoring.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 100
Est. completion date June 28, 2024
Est. primary completion date June 28, 2024
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: Patients monitored by using Tempus Pro during pre-hospital care (ambulance transportation) One or more 12-lead ECG recorded Use of 3 or more of the following sensors to measure vital signs - NIBP (Non-Invasive Blood Pressure) - HR (Heart Rate) - SpO2 (Oxygen Saturation) - PVI (Pleth Variability Index) - SpCO (Carboxyhemoglobin) - SpOC (Oxygen Content) - SpHb (Total Hemoglobin) - SpMet (Methemoglobin Saturation) - EtCO2 (End-tidal Carbon Dioxide) Exclusion Criteria: - None defined

Study Design


Intervention

Diagnostic Test:
Standard of Care
Standard of care for emergency events per local guidelines.

Locations

Country Name City State
United States Philips Pittsburgh Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
Philips Clinical & Medical Affairs Global North American Science Associates, LLC

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Adverse Device Effects Frequency of Adverse Device Effects (ADE) related to device users - collected from Incident Reporting through study completion, an average of 1 year
Other Device Deficiencies Frequency of Device Deficiencies (DD) - data collected from the technical data log recorded in the Tempus Pro at each Monitoring Event and from Product Complaint Reports through study completion, an average of 1 year
Primary Clinician assessment of 12-lead ECG reports The proportion of 12-lead ECG pairs that are identical, after a cardiologist's review of printouts from Corsium IntelliSpace (transmitted) ECG and the original ECG from the Tempus Pro device. through study completion, an average of 1 year
Primary Diagnostic quality of 12-lead The printed patient record ECG will be independently reviewed for abnormalities and distortion by a clinician. The clinician will note any abnormalities altering diagnostic quality. through study completion, an average of 1 year
Primary Consistency of transmitted vital signs by Tempus Pro via IntelliSpace Corsium The number and proportion of patient vital sign data points, comparing direct data with identical units of measure from printouts from IntelliSpace Corsium (transmitted) vital signs and the original vital signs from the Tempus Pro device. through study completion, an average of 1 year
Secondary Number of all activated alarms The 'Summary Record of Care' indicates all alarms - for all alarm-settable parameters - were activated at the thresholds set by the user, as indicated in the 'Technical Log' through study completion, an average of 1 year
Secondary IntelliSpace Corsium transmission The Summary Record of Care (SRoC) data transmission from Tempus Pro to IntelliSpace Corsium will be independently reviewed for abnormalities and distortion by a clinician. The clinician will note any abnormalities altering diagnostic quality of the transmission. through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Completed NCT00226681 - Nurses Helping Sudden Cardiac Arrest Survivors Recover After Getting An Implantable Cardioverter Defibrillator (ICD) Phase 1
Recruiting NCT05799833 - Low QRS Voltages in Young Healthy Individuals and Athletes
Completed NCT05636332 - The Intrepid Clinical Engineering Study N/A
Recruiting NCT04250857 - HeartStart FRx Defibrillator Event Registry
Recruiting NCT02816047 - Austrian Wearable Cardioverter Defibrillator Registry
Completed NCT00918125 - Educational Videos to Improve Patient Decision Making and Race Disparities in Implantable Cardioverter Defibrillator Use N/A
Recruiting NCT05135403 - ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Completed NCT03715790 - Improve SCA Bridge Study
Recruiting NCT03826524 - Epinephrine Dose: Optimal Versus Standard Evaluation Trial Phase 4
Recruiting NCT05855135 - Assessment of Combined CCM and ICD Device in HFrEF N/A
Completed NCT03065647 - ECPR for Refractory Out-Of-Hospital Cardiac Arrest N/A
Completed NCT02099721 - Improve Sudden Cardiac Arrest Study N/A
Recruiting NCT01822145 - A Feasibility Study on Prediction of an ICD Shock by ICD-derived Data N/A
Completed NCT01326624 - Study of the Wearable Defibrillator in Heart-Failure Patients N/A
Completed NCT03016754 - Heart Failure Optimization Study
Terminated NCT02481206 - Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study N/A
Not yet recruiting NCT06447805 - Early Double Sequential Defibrillation in Out-of-hospital Cardiac Arrest N/A
Enrolling by invitation NCT04548804 - Better Mechanistic Understanding of and Risk Stratification for Ventricular Tachyarrhythmias Through ECGI N/A
Completed NCT05490459 - Jewel Electrophysiology (EP) Lab Study N/A
Recruiting NCT01521208 - LUCAS Chest Compressor Versus Manual Chest Compression in Out-of-hospital Sudden Cardiac Arrest. LUCAT Trial Phase 3